Adalimumab

ATC Code L04AB04

Adalimumab

Definition

A recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases.

Also known as ABP 501, ADALIMUMAB, Adalimumab Biosimilar ABP 501, D2E7, Humira, Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer, LU200134 — per NCIT

Also identified as

Indications

Disease Relation Source
Ankylosing spondylitis may treat MEDRT · Public domain (U.S. Government work)
Crohn's disease may treat MEDRT · Public domain (U.S. Government work)
Hidradenitis suppurativa may treat MEDRT · Public domain (U.S. Government work)
Juvenile idiopathic arthritis may treat MEDRT · Public domain (U.S. Government work)
Psoriatic arthritis may treat MEDRT · Public domain (U.S. Government work)
Rheumatoid arthritis may treat MEDRT · Public domain (U.S. Government work)
Ulcerative colitis may treat MEDRT · Public domain (U.S. Government work)
Uveitis may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Alimentary part of gastrointestinal system may treat a disease of this organ DERIVED · CC BY 4.0
Bone element may treat a disease of this organ DERIVED · CC BY 4.0
Camera-type eye may treat a disease of this organ DERIVED · CC BY 4.0
Intestine may treat a disease of this organ DERIVED · CC BY 4.0
Musculoskeletal system may treat a disease of this organ DERIVED · CC BY 4.0
Skeletal joint may treat a disease of this organ DERIVED · CC BY 4.0
Uvea may treat a disease of this organ DERIVED · CC BY 4.0

7 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.